DCF — WASHAKIE MEDICAL CENTER
Enterprise Value: $-12.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-12.1M
Enterprise Value
$-4.5M
PV of Cash Flows
$-7.5M
PV of Terminal Value
$-12.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $29.0M | $-0.4M | -1.0% | $-1.6M | $-1.4M |
| Year 2 | $29.8M | $-0.1M | -0.0% | $-1.3M | $-1.1M |
| Year 3 | $30.7M | $0.2M | 1.0% | $-1.1M | $-0.8M |
| Year 4 | $31.7M | $0.4M | 1.0% | $-0.9M | $-0.6M |
| Year 5 | $32.6M | $0.5M | 2.0% | $-0.9M | $-0.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-12.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$28.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.017378949470823312
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5